Inmune Bio

Inmune Bio

INMB· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -66.6% in FY2025

David J. Moss is the CEO of Inmune Bio and was paid $1.8M in FY2025 (Dec), down 32%.

Pay$100 in the stock at the end of FY21 → $15
CEO pay is from each Inmune Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Raymond J. TesiFY2025
  2. 2David J. MossFY2025
  3. 3Mark LowdellFY2025
  4. 4Cory EllspermannFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Inmune Bio paid its 4 named executives $6.8M in total in FY2025 (Dec). CEO David J. Moss was paid $1.8M of that.

Name
Raymond J. TesiM.D., former CEO, President and CMO
David J. MossCEO and President
Mark LowdellNot disclosed
Cory EllspermannCFONot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Inmune Bio. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 23, 2026FY2025
Annual report10-KMar 30, 2026FY2025
Proxy statementDEF 14AApr 21, 2025FY2024
Annual report10-KMar 27, 2025FY2024
Proxy statementDEF 14AMay 29, 2024FY2023
Annual report10-KMar 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data